Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kamux Corporation: Share repurchase 4.4.2024

Kamux Corporation, Stock Exchange Release, 4.4.2024 at 18:30 Kamux Corporation: Share repurchase 4.4.2024 In the Helsinki Stock Exchange Trade date          4.4.2024  Bourse trade        Buy  Share                 KAMUX  Amount            8,179 SharesAverage price/ share   5.9180 EURTotal cost           48,403.32 EUR   Kamux Corporation now holds a total of 78,907 shares including the shares repurchased on 4.4.2024.              On behalf of Kamux CorporationNordea Bank Oyj  Janne Sarvikivi           Sami Huttunen

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 04.04.2024

United Bankers Plc NOTIFICATION   04.04.2024 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 04.04.2024   Date 04.04.2024  Exchange transaction Buy  Share class UNITED  Amount 360  Average price/share 17.3000 EURHighest price/share 17.3000 EURLowest price/share 17.3000 EURTotal price 6,228.00   EUR        The shares held by United Bankers Plc on 04.04.2024   UNITED 2,549         On behalf of United

Report from the annual general meeting in NAXS AB (publ) on 4 April 2024

On 4 April 2024 the annual general meeting of NAXS AB (publ) resolved in accordance with the following Adoption of the annual accounts, distribution of profit, etc. •   The annual general meeting adopted the income statements and balance sheets for the parent company and the group for the year 2023 and resolved that SEK 4.25 per share shall be allocated as dividends to the shareholders and that the remaining unrestricted equity shall be carried forward. •   The annual general meeting resolved to discharge the board members and the managing director from liability. Board of

#24-122 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-121 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Changes in Nordea’s own shares

Nordea Bank AbpStock exchange release – Changes in company’s own shares4 April 2024 at 18.00 EET A total of 1,272,434 own shares held by the company were today transferred without consideration to participants of Nordea Bank Abp’s variable remuneration programmes. Based on the resolution of the Board of Directors announced on 21 March 2024, Nordea has transferred 1,272,434 own shares held by the company to settle its commitments to participants of its variable remuneration programmes. Following the transfer of own shares, Nordea holds 3,514,881 treasury shares for remuneration

UPM Raflatac Receives APR Design® for Recyclability Recognitions for Three Types of BOPP Label Solutions

(UPM Raflatac, Mills River, NC, US, April 4, 2024 at 11:00 EST) – UPM Raflatac, a global supplier of innovative and sustainable self-adhesive paper and film products, has been formally recognized by the Association of Plastic Recyclers (APR) for three types of biaxially-oriented polypropylene (BOPP) label products for HDPE and PP package recycling. These include Undecorated BOPP with hotmelt adhesive, Undecorated BOPP with RW85C, and Metalized undecorated BOPP with general purpose acrylic adhesive. “We are honored to once again be recognized for our continued commitment to supporting the

New analysis reveals which money transfer companies have the best customer ratings

· New analysis  from FXC Intelligence reveals the money transfer companies with the best customer ratings in the latest report from the market leading provider of cross-border data and intelligence. · In a landscape where digital is becoming increasingly prevalent, online reviews are a valuable indicator of the focus companies are placing on their digital growth. · Of the 12 companies we assessed for this report, most had strong combined customer ratings in 2024.Today, FXC Intelligence published its

Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure

Under Danish law the company can during a reconstrution phase resolve on creditor issues and access certain loans.“Qlife is following our operational plans, but since we have a called for an extraordinary general meeting later this month to resolve on the company’s balance sheet, we have chosen at the same time to use this measure under Danish law to resolve some creditors issues. We consider this step as an additional option to secure the liquidity balance in the short term.”, says Thomas Warthoe CEO of Qlife.

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B62Z3C74 Issuer Name Fidelity China Special Situations PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name FIL Limited City of registered office (if applicable) Hamilton Country of registered office (if applicable) Bermuda 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification

Outokumpu’s Board of Directors’ decisions on the composition of the Board committees at their first meeting

Outokumpu CorporationStock exchange releaseApril 4, 2024 at 4.30 pm EESTOutokumpu’s Board of Directors’ decisions on the composition of the Board committees at their first meeting Outokumpu Oyj’s Board of Directors has at its first meeting appointed two permanent committees, the Audit Committee and the Remuneration Committee, and decided on their composition. To the Audit Committee the Board elected Jyrki Mäki-Kala as the Chairman and Päivi Luostarinen, Petter Söderström and Julia Woodhouse as members. To the Remuneration Committee the Board elected Kari Jordan as the Chairman

Rollover of Director's REPO

4 April 2023   Quantum Blockchain Technologies Plc(“the Company”)     Rollover of Director’s REPO   Following previous announcements made by the Company regarding the rollover of the Sale & Repurchase Agreement (the “REPO”) entered into between the Company’s CEO and Executive Chairman, Professor Francesco Gardin, and MC Strategies AG (“MCS”), the Company has been informed that Professor Gardin and MCS have agreed to amend the repurchase price and the repurchase date of the REPO as follows: · The term of the REPO under which Professor Gardin is to repurchase 5,000,

Nel ASA: Additional USD 41 million in tax credits for manufacturing expansion in Michigan

(April 4, 2024 - Oslo, Norway, Nel, OSE:NEL). Nel has been awarded up to USD 41 million in investment tax credits for its planned manufacturing expansion in Michigan as part of the Qualifying Advanced Energy Project Tax Credit (48C) program.“We continue to see strong support for our efforts to scale our US operations, both within advanced research and efficient manufacturing. The support now received increases the attractiveness of investing in expanding our capacity and capability in the US,” says Nel’s President and CEO, Håkon Volldal. The 48C program is funded by the Inflation

Dignitana’s rights issue fully subscribed

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS WHOLLY OR PARTIALLY SUBJECT TO LEGAL RESTRICTIONS. SEE ALSO THE "IMPORTANT INFORMATION" SECTION BELOW. Dignitana AB (publ) ("Dignitana" or the "Company") today, on 4 April 2024, announces the outcome of the rights issue of shares that was announced through a press release on 21 February 2024 (the "Rights

RaySearch to present latest innovations in RayStation, RayCare and RayIntelligence at ISOP and NPC (NAPT)

RaySearch Laboratories AB (publ) will present the latest software innovations at IBA’s International Symposium on Proton Therapy (ISOP) in Boston, Massachusetts, April 5, and at the National Proton Conference (NPC) run by the National Association on Proton Therapy (NAPT) in Boston, April 6-9. Visit us at RaySearch’s table at ISOP and booth at NPC.The focus during both ISOP and NPC will be on support for proton arcs and robust optimization based on linear energy transfer (LET) and adaptive therapy. Further, new features in RayStation®* 2023B related to proton therapy will be highlighted.

OncoZenge Announces Read-out of Positive Stability Data for BupiZenge™

Stockholm, Sweden – April 4, 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid based treatment for oral pain, announces today that ongoing stability studies for the revised formulation of BupiZenge™ show positive results.Stability studies of BupiZenge™ are ongoing in line with previous communication from the company. The data now obtained shows 3 months of positive results within the desired limits of the specification for the development of the latest formulation. This data complements earlier data and analyzes and confirms the

Resolutions of Outokumpu’s Annual General Meeting 2024

Outokumpu CorporationStock exchange releaseApril 4, 2024 at 4.00 pm EESTResolutions of Outokumpu’s Annual General Meeting 2024 Outokumpu’s Annual General Meeting 2024 was held today on April 4, 2024 at the Clarion Hotel Helsinki in Helsinki, Finland. The Annual General Meeting supported all of the proposals by the Board of Directors and the Shareholders’ Nomination Board. The Annual General Meeting approved the financial statements and discharged the Board of Directors and the CEO of the company from liability for the financial year 2023. The Annual General Meeting decided that a

Conference call interim report

Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1, 2024. The presentation will be held in English.Time: Thursday 18 April, 2024 at 10.00 a.m. CET. To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group 

Henrik Ehrnrooth to continue as the Chair of the Board of Directors of UPM-Kymmene Corporation

UPM-Kymmene Corporation        Stock Exchange Release (Other information disclosed according to the rules of the Exchange)        4 April 2024 at 15:50 EEST Henrik Ehrnrooth to continue as the Chair of the Board of Directors of UPM-Kymmene Corporation Henrik Ehrnrooth was elected as Chair, and Kim Wahl as Deputy Chair of the Board of Directors of UPM-Kymmene Corporation at the Board of Directors’ constitutive meeting that took place today following the Annual General Meeting. In addition, the Board of Directors elected the chairs and other members to the Board committees from among

Enhancing Isku’s furniture production with a new biobased, non-staining adhesive

Isku has switched to Kiilto’s biobased, pH-neutral Kiilto Pro WRX 3070 adhesive in its furniture production. The new adhesive also has very low formaldehyde content. The change of adhesive has improved the quality, productivity and safety of Isku’s production process.Finnish furniture manufacturer Isku  recently started using Kiilto’s biobased Kiilto Pro WRX 3070  adhesive, developed specifically for the furniture industry. D3 class PVAc adhesives are used in the wood manufacturing industry for products such as doors,

Medivir 2023 Annual Report published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2023 now is available at the company’s website: www.medivir.com. In the fall of 2023, very promising data from the ongoing phase 1b/2a study with Medivir's spearhead project fostrox in combination with Lenvima[®] were presented. The combination has shown continued improved clinical benefit in patients with advanced primary liver cancer (HCC) and at ASCO-GI in January 2024, data were presented showing further increases in the proportion of patients achieving a clinically relevant reduction

Borr Drilling Limited - Contracting update

Borr Drilling Limited (the “Company”) (NYSE and OSE: “BORR”) has today received a notice of temporary suspension of operations for its rig “Arabia I”, operating in Saudi Arabia. The temporary suspension will be for a period of up to 12 months, and is expected to commence in the second quarter. The Company intends to seek alternative engagement for the rig while on suspension. Hamilton, Bermuda 4 April 2024 Forward looking statements This press release includes forward looking statements, which do not reflect historical facts and may be identified by words such as “expected”, “

The Nomination Committee announces its proposal for changes to the Board of Directors

The Nomination Committee of Kebni AB (publ) has put forward the following proposal for changes to the Board of Directors ahead of the Annual General Meeting, which will be held on May 16[th], 2024. The Nomination Committee has communicated the following proposal to the company, which the company hereby discloses. For the Board of Directors, the re-election of Jan Wäreby and Magnus Edman are proposed, along with the new election of Anders Persson, Anna-Karin Stenberg and Martin Elovsson. Anders Persson is proposed to be elected as the Chairman of the Board.  More information about

CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia

CS MEDICA is now set to launch its CANNASEN® Protective Nasal Gel for sale in the first Asian market.CS MEDICA announces the Malaysian approval of CANNASEN® Protective Nasal Gel. This important approval not only brings an innovative product to the market but symbolizes CS MEDICA's breakthrough in overcoming the complex regulatory barriers in Asia.  A Milestone for CS MEDICA Lone Henriksen, CEO of CS MEDICA, comments, "This approval is a monumental achievement for CS MEDICA. Our journey to this point has been marked by a commitment to our goals and a persistent determination to

There are no items matching the current filter
There are no more items matching the current filter
Back to top